生物标志物 生物标志物
Xinyi Lyu1, Feng Gao2, Xiaodong Pan3
1Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
这项研究比较了中国阿尔茨海默病 (AD) 检测的血液生物标志物,评估了它们与PET扫描的准确性. 这些发现将有助于利用可靠的血液检测优化早期AD查.
科学领域:
- 神经学 神经学
- 生物标志物发现发现
- 医学诊断 医学诊断 医学诊断
背景情况:
- 阿尔茨海默病 (AD) 诊断依赖于侵入性方法,血液生物标志物显示出有希望但缺乏标准化检测.
- 目前血液生物标志物检测的不一致性阻碍了AD查和诊断的广泛临床应用.
研究的目的:
- 为了进行商业上可用的血液生物标志物的对比比较,用于阿尔茨海默病 (AD) 检测.
- 评估血生物标志物 (Aβ40,Aβ42,t-tau,p-tau) 的灵敏度和特异性,以预测由Aβ-PET证实的粉样蛋白病理.
- 在中国人口中优化AD查和诊断的临床途径.
主要方法:
- CLEAR-AD研究是中国的一项横截面研究,涉及400名不同认知状态 (认知正常,MCI,痴呆) 的参与者.
- 参与者接受了粉样蛋白位子发射断层扫描 (Aβ-PET) 扫描.
- 使用各种检测方法 (例如单分子免疫检测,数字免疫检测芯片) 在盲目的条件下测量等离子体生物标志物,并与Aβ-PET结果进行比较.
主要成果:
- 该研究评估了血生物标志物的诊断准确性与Aβ-PET作为参考标准.
- 接收器操作特征 (ROC) 曲线被生成以确定生物标志物检测的最佳切断值.
- 开发了一个整合多个生物标志物和临床数据的预测模型,以提高诊断能力.
结论:
- 这项CLEAR-AD研究提供了关于商业血液生物标志物对预测阿尔茨海默病 (AD) 粉样蛋白病理学的性能的基本数据.
- 这些发现将有助于优化早期AD查策略,特别是在中国人群中.
- 预计这些结果将指导开发更有效的AD诊断工具.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516